Plain-English translation of NCT05318105 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The REVERSE-HF study compared two ways to help people hospitalized with worsening heart failure and too much fluid in their bodies. One group received treatment with the Aquadex System, a machine that gently removes excess fluid from the blood, while the other group received (strong water pills given through an IV). The trial wanted to see which approach was safer and more effective at improving outcomes.
When heart failure gets worse, patients often have dangerous amounts of fluid building up in their bodies and lungs. Standard IV water pills help remove this fluid, but doctors wanted to know if this fluid removal machine might work better or safer for these very sick patients.
If you enrolled, you would be randomly assigned to receive either the Aquadex fluid removal therapy or standard IV water pills while in the hospital. The study team would monitor your fluid levels, kidney function, and overall heart health during your hospitalization and follow-up period. Your participation would involve hospital visits and follow-up care to track how well the treatment worked for your heart failure.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
United States